CHELSEA BARTLETT: Open Payments
NPI 1598140857 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 67 payments from 17 companies in 2025. Trend: 2023 $747 · 2024 $1,574 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $294 |
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| Lilly USA, LLC | 13 | $125 |
| PFIZER INC. | 6 | $105 |
| Amgen Inc. | 5 | $78 |
| Exact Sciences Corporation | 4 | $77 |
| ABBVIE INC. | 3 | $53 |
| Medtronic, Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Mannkind Corporation | 1 | $35 |
Products named: FARXIGA, MOUNJARO, Ozempic, Wegovy, The Cologuard Plus Collection Kit, PREVNAR 20, NURTEC ODT, SYNCHROMEDII.
Industry payments across VA — which companies pay providers there.
